Carcinoembryonic Antigen-Related Cellular Adhesion Molecule 1 Isoforms Alternatively Inhibit and Costimulate Human T Cell Function1

Carcinoembryonic Ag-related cellular adhesion molecule 1 (CEACAM1) represents a group of transmembrane protein isoforms that consist of variable numbers of extracellular Ig-like domains together with either a long cytoplasmic (cyt) tail containing two immunoreceptor tyrosine-based inhibitory motifs or a unique short cyt tail. Although CEACAM1 has been reported to be expressed on the surface of T lymphocytes upon activation, its roles in T cell regulation are controversial due to the lack of functional characterization of each individual CEACAM1 isoform. We thus cotransfected Jurkat T cells with CEACAM1 isoform-encoding constructs and an IL-2 promoter-bearing plasmid or a small interference RNA targeting src homology domain 2 containing phosphatase 1. In a luciferase reporter assay and through measurements of cytokine secretion (IL-2, IL-4, and IFN-γ), CEACAM1 containing either a long or a short cyt tail inhibited or costimulated, respectively, TCR/CD3 complex plus CD28 mediated activation with the inhibitory functions of the long cyt tail dominating. The inhibitory function of CEACAM1, was dependent upon src homology domain 2 containing phosphatase 1 activity, required both tyrosine residues within the immunoreceptor tyrosine-based inhibitory motif domains of the cyt tail and was mediated through the mitogen-activated protein kinase pathway. CEACAM1-mediated inhibition could be functionally reconstituted by incubation of PBMC with either a CEACAM1-specific mAb or CEACAM1-Fc fusion protein in the presence of an allogeneic or mitogenic stimulus, respectively. These studies indicate that the long and short cyt tails of CEACAM1 serve as inhibitory and costimulatory receptors, respectively, in T cell regulation.

[1]  D. Golenbock,et al.  Phagocytosis, Innate Immunity, and Host–Pathogen Specificity , 2004, The Journal of experimental medicine.

[2]  M. Neurath,et al.  Specific regulation of T helper-1 mediated murine colitis by CEACMI , 2003 .

[3]  Pingfang Liu,et al.  CEACAM1-4S, a cell–cell adhesion molecule, mediates apoptosis and reverts mammary carcinoma cells to a normal morphogenic phenotype in a 3D culture , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. Hanna,et al.  Pivotal role of CEACAM1 protein in the inhibition of activated decidual lymphocyte functions. , 2002, The Journal of clinical investigation.

[5]  T. Rana,et al.  RNAi in human cells: basic structural and functional features of small interfering RNA. , 2002, Molecular cell.

[6]  M. Ogimoto,et al.  Src Homology Region 2 Domain-Containing Phosphatase 1 Positively Regulates B Cell Receptor-Induced Apoptosis by Modulating Association of B Cell Linker Protein with Nck and Activation of c-Jun NH2-Terminal Kinase1 , 2002, The Journal of Immunology.

[7]  K. Sigmundsson,et al.  Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Expression and Signaling in Human, Mouse, and Rat Leukocytes: Evidence for Replacement of the Short Cytoplasmic Domain Isoform by Glycosylphosphatidylinositol-Linked Proteins in Human Leukocytes1 , 2002, The Journal of Immunology.

[8]  N. Duke,et al.  Crystal structure of murine sCEACAM1a[1,4]: a coronavirus receptor in the CEA family , 2002, The EMBO journal.

[9]  S. Gray-Owen,et al.  Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4+ T lymphocytes , 2002, Nature Immunology.

[10]  R. Raychowdhury,et al.  Activation-Induced Expression of Carcinoembryonic Antigen-Cell Adhesion Molecule 1 Regulates Mouse T Lymphocyte Function1 , 2002, The Journal of Immunology.

[11]  Chen Dong,et al.  MAP kinases in the immune response. , 2002, Annual review of immunology.

[12]  P. Bates,et al.  Homophilic adhesion of human CEACAM1 involves N-terminal domain interactions: structural analysis of the binding site. , 2001, Blood.

[13]  A. Maeda,et al.  Biliary glycoprotein (BGPa, CD66a, CEACAM1) mediates inhibitory signals , 2001, Journal of leukocyte biology.

[14]  M. Rincón MAP-kinase signaling pathways in T cells. , 2001, Current opinion in immunology.

[15]  J. Reimann,et al.  Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 on Murine Dendritic Cells Is a Potent Regulator of T Cell Stimulation1 , 2001, The Journal of Immunology.

[16]  L. Lanier,et al.  Immune inhibitory receptors. , 2000, Science.

[17]  Jun Wu,et al.  Dap10 and Dap12 Form Distinct, but Functionally Cooperative, Receptor Complexes in Natural Killer Cells , 2000, The Journal of experimental medicine.

[18]  C. Rochlitz,et al.  Locally inducible CD66a (CEACAM1) as an amplifier of the human intestinal T cell response , 2000, European journal of immunology.

[19]  Y. Arimura,et al.  Src Homology Region 2 (SH2) Domain-Containing Phosphatase-1 Dephosphorylates B Cell Linker Protein/SH2 Domain Leukocyte Protein of 65 kDa and Selectively Regulates c-Jun NH2-Terminal Kinase Activation in B Cells1 , 2000, The Journal of Immunology.

[20]  T. Tedder,et al.  CD22 Forms a Quaternary Complex with SHIP, Grb2, and Shc , 2000, The Journal of Biological Chemistry.

[21]  L. Serino,et al.  Carcinoembryonic antigens are targeted by diverse strains of typable and non‐typable Haemophilus influenzae , 2000, Molecular microbiology.

[22]  A. Skubitz,et al.  Synthetic Peptides of CD66a Stimulate Neutrophil Adhesion to Endothelial Cells1 , 2000, The Journal of Immunology.

[23]  S. Ergün,et al.  CEA-related cell adhesion molecule 1: a potent angiogenic factor and a major effector of vascular endothelial growth factor. , 2000, Molecular cell.

[24]  Y. Sun,et al.  Essential role of biliary glycoprotein (CD66a) in morphogenesis of the human mammary epithelial cell line MCF10F. , 1999, Journal of cell science.

[25]  F. Grunert,et al.  Critical determinants of host receptor targeting by Neisseria meningitidis and Neisseria gonorrhoeae : identification of Opa adhesiotopes on the N‐domain of CD66 molecules , 1999, Molecular microbiology.

[26]  W. Zimmermann,et al.  Redefined nomenclature for members of the carcinoembryonic antigen family. , 1999, Experimental cell research.

[27]  N. Beauchemin,et al.  cis-Determinants in the cytoplasmic domain of CEACAM1 responsible for its tumor inhibitory function , 1999, Oncogene.

[28]  M. Bos,et al.  Homologue Scanning Mutagenesis Reveals Cd66 Receptor Residues Required for Neisserial Opa Protein Binding , 1999, The Journal of experimental medicine.

[29]  G. Freeman,et al.  Regulation of human intestinal intraepithelial lymphocyte cytolytic function by biliary glycoprotein (CD66a). , 1999, Journal of immunology.

[30]  S. Hammarström The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. , 1999, Seminars in cancer biology.

[31]  R. Perlmutter,et al.  T cell antigen receptor-mediated activation of the Ras/mitogen-activated protein kinase pathway controls interleukin 4 receptor function and type-2 helper T cell differentiation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[32]  N. Beauchemin,et al.  The Carboxyl-terminal Region of Biliary Glycoprotein Controls Its Tyrosine Phosphorylation and Association with Protein-tyrosine Phosphatases SHP-1 and SHP-2 in Epithelial Cells* , 1999, The Journal of Biological Chemistry.

[33]  S. von Kleist,et al.  Biliary glycoprotein (CD66a), a cell adhesion molecule of the immunoglobulin superfamily, on human lymphocytes: structure, expression and involvement in T cell activation , 1998, European journal of immunology.

[34]  R. Flavell,et al.  Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2. , 1998, Immunity.

[35]  S. Gullans,et al.  Prevention of acute allograft rejection by antibody targeting of TIRC7, a novel T cell membrane protein. , 1998, Immunity.

[36]  J. C. Pratt,et al.  The Small GTP-Binding Protein Rho Potentiates AP-1 Transcription in T Cells , 1998, Molecular and Cellular Biology.

[37]  N. Beauchemin,et al.  Mutational Analysis of the Virus and Monoclonal Antibody Binding Sites in MHVR, the Cellular Receptor of the Murine Coronavirus Mouse Hepatitis Virus Strain A59 , 1998, Journal of Virology.

[38]  N. Beauchemin,et al.  Optimal ratios of biliary glycoprotein isoforms required for inhibition of colonic tumor cell growth. , 1997, Cancer research.

[39]  A. Cattaneo,et al.  Targeting vectors for intracellular immunisation. , 1997, Gene.

[40]  N. Beauchemin,et al.  Association of biliary glycoprotein with protein tyrosine phosphatase SHP-1 in malignant colon epithelial cells , 1997, Oncogene.

[41]  C. Rudd,et al.  Regulation of Vav-SLP-76 binding by ZAP-70 and its relevance to TCR zeta/CD3 induction of interleukin-2. , 1997, Immunity.

[42]  J. Rast,et al.  α, β, γ, and δ T Cell Antigen Receptor Genes Arose Early in Vertebrate Phylogeny , 1997 .

[43]  C. Godfraind,et al.  B lymphocyte and macrophage expression of carcinoembryonic antigen‐related adhesion molecules that serve as receptors for murine coronavirus , 1994, European journal of immunology.

[44]  N. Beauchemin,et al.  Several members of the mouse carcinoembryonic antigen-related glycoprotein family are functional receptors for the coronavirus mouse hepatitis virus-A59 , 1993, Journal of virology.

[45]  C. Dieffenbach,et al.  Cloning of the mouse hepatitis virus (MHV) receptor: expression in human and hamster cell lines confers susceptibility to MHV , 1991, Journal of virology.

[46]  M. de Souza,et al.  Monoclonal Antibody to the Receptor for Murine Coronavirus MHV-A59 Inhibits Viral Replication In Vivo , 1991, The Journal of infectious diseases.

[47]  F. Grunert,et al.  Carcinoembryonic antigen gene family: Molecular biology and clinical perspectives , 1991, Journal of clinical laboratory analysis.